Evidence map›Paper›PMID 28138935›Full record

ArticleMarine biotechnology (New York, N.Y.)2017

Immunostimulatory Effect of Enzyme-Modified Hizikia fusiformein a Mouse Model In Vitro and Ex Vivo.

Sang-Yong Park, Eunson Hwang, Yu-Kyong Shin, Don-Gil Lee, Jung-Eun Yang, Jae-Hee Park, Tae-Hoo Yi

Abstract read
PubMed Publisher
In one paragraph

Article in Marine biotechnology (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Foods (Basel, Switzerland) · 2021
    Review
  8. Preparation of NewMolecules (Basel, Switzerland) · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sang-Yong ParkDepartment of Oriental Medicinal Materials & Processing, College of Life Science, Kyung Hee University, Yongin-si, South Korea.
Eunson HwangDepartment of Oriental Medicinal Materials & Processing, College of Life Science, Kyung Hee University, Yongin-si, South Korea.
Yu-Kyong ShinDepartment of Oriental Medicinal Materials & Processing, College of Life Science, Kyung Hee University, Yongin-si, South Korea.
Don-Gil LeeGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-Si, South Korea.
Jung-Eun YangGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-Si, South Korea.
Jae-Hee ParkGraduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-Si, South Korea.
Tae-Hoo YiDepartment of Oriental Medicinal Materials & Processing, College of Life Science, Kyung Hee University, Yongin-si, South Korea. drhoo@khu.ac.kr.
Kyung Hee University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hizikia fusiforme, a brown seaweed, has been utilized as a health food and in traditional medicine. In this study, we investigated whether enzyme-modified H. fusiforme extracts (EH) have immunological effects compared with normal H. fusiforme extracts (NH). The effects of NH and EH on immune responses were investigated by assessing nitric oxide (NO) production, phagocytosis, and cytokine secretion in RAW 264.7 murine macrophages and mice. Also, fucosterol was evaluated to find the active component of NH and EH by addressing cytotoxicity test and NO production. Both of NH and EH significantly increased cell viability and NO synthesis. Tumor necrosis factor-α (TNF-α) expression was more induced by EH with LPS treatment. Phagocytic activity, as the primary function of macrophages, was markedly induced by EH treatment. Additionally, EH encouraged splenocyte proliferation and recovered the levels of cytokines IL-1β, IL-6, and TNF-α in mice. Finally, fucosterol increased NO production with no cytotoxicity, which means that fucosterol is an active component of EH. In conclusion, EH has the potential to modulate immune function and could offer positive therapeutic effect for immune system diseases.

Indexed as

AnimalsCell LineCell SurvivalGene ExpressionImmunologic FactorsInterleukin-1betaInterleukin-6LipopolysaccharidesLymphocytesMacrophagesMiceNitric OxidePhaeophyceaePhagocytosisPrimary Cell CultureSeaweedfucosterolIL1B protein, mouseImmunologic FactorsInterleukin-1betaInterleukin-6interleukin-6, mouseLipopolysaccharidesNitric OxideStigmasterolTumor Necrosis Factor-alphaEnzyme-modifiedEx vivoFucosterolHizikia fusiformeImmunostimulatory effect

Identifiers

PMID28138935
OpenAlexW2582323354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.